Cargando…

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

BACKGROUND: High-density oligomers of the prion protein (HDPs) have previously been identified in brain tissues of patients with rapidly progressive Alzheimer’s disease (rpAD). The current investigation aims at identifying interacting partners of HDPs in the rpAD brains to unravel the pathological i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafiq, Mohsin, Zafar, Saima, Younas, Neelam, Noor, Aneeqa, Puig, Berta, Altmeppen, Hermann Clemens, Schmitz, Matthias, Matschke, Jakob, Ferrer, Isidre, Glatzel, Markus, Zerr, Inga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898440/ https://www.ncbi.nlm.nih.gov/pubmed/33618749 http://dx.doi.org/10.1186/s13024-021-00422-x

Ejemplares similares

Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer’s Disease
por: Noor, Aneeqa, et al.
Publicado: (2021)

SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease
por: Younas, Neelam, et al.
Publicado: (2020)

SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease Patients
por: Zafar, Saima, et al.
Publicado: (2022)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
por: Schmitz, Matthias, et al.
Publicado: (2023)

Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein
por: Mohammadi, Behnam, et al.
Publicado: (2022)

Differential interactome mapping of aggregation prone/prion-like proteins under stress: novel links to stress granule biology
por: Younas, Neelam, et al.
Publicado: (2023)

Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
por: Noor, Aneeqa, et al.
Publicado: (2021)

Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
por: Matamoros-Angles, Andreu, et al.
Publicado: (2023)

The role of cellular prion protein in lipid metabolism in the liver
por: Arora, Amandeep Singh, et al.
Publicado: (2020)

Animal TSEs and public health: What remains of past lessons?
por: Zafar, Saima, et al.
Publicado: (2018)

Unveiling the Physical and Functional Niches of FAM26F by Analyzing Its Subcellular Localization and Novel Interacting Partners
por: Malik, Uzma, et al.
Publicado: (2020)

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
por: Cramm, Maria, et al.
Publicado: (2014)

Disordered structure and flexible roles: using the prion protein N1 fragment for neuroprotective and regenerative therapy
por: Mohammadi, Behnam, et al.
Publicado: (2020)

Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation
por: Mohammadi, Behnam, et al.
Publicado: (2020)

Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients
por: Schmitz, Matthias, et al.
Publicado: (2016)

Show Me Your Friends and I Tell You Who You Are: The Many Facets of Prion Protein in Stroke
por: Puig, Berta, et al.
Publicado: (2020)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
por: Zerr, Inga, et al.
Publicado: (2020)

Genetic Variants Associated with the Age of Onset Identified by Whole-Exome Sequencing in Fatal Familial Insomnia
por: Thüne, Katrin, et al.
Publicado: (2023)

Cellular prion protein mediates early apoptotic proteome alternation and phospho-modification in human neuroblastoma cells
por: Zafar, Saima, et al.
Publicado: (2017)

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives
por: Kanata, Eirini, et al.
Publicado: (2018)

Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
por: Linsenmeier, Luise, et al.
Publicado: (2021)

Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice
por: Puig, Berta, et al.
Publicado: (2016)

Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
por: Linsenmeier, Luise, et al.
Publicado: (2018)

Subtype and Regional-Specific Neuroinflammation in Sporadic Creutzfeldt–Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2014)

Prion2022-pushing the boundaries
por: Zerr, Inga
Publicado: (2023)

The sheddase ADAM10 is a potent modulator of prion disease
por: Altmeppen, Hermann C, et al.
Publicado: (2015)

GPI-anchor signal sequence influences PrP(C) sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice
por: Puig, Berta, et al.
Publicado: (2019)

Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie
por: Schmitz, Matthias, et al.
Publicado: (2016)

Human prion diseases: progress in clinical trials
por: Zerr, Inga
Publicado: (2013)

Prion 2022 Conference abstracts: pushing the boundaries
por: Zerr, Inga
Publicado: (2022)

Loss of Homeostatic Microglia Signature in Prion Diseases
por: Wang, Yue, et al.
Publicado: (2022)

Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo
por: Altmeppen, Hermann C, et al.
Publicado: (2011)

RNA editing alterations define manifestation of prion diseases
por: Kanata, Eirini, et al.
Publicado: (2019)

Characterization of brain-derived extracellular vesicles reveals changes in cellular origin after stroke and enrichment of the prion protein with a potential role in cellular uptake
por: Brenna, Santra, et al.
Publicado: (2020)

Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein
por: Roettger, Yvonne, et al.
Publicado: (2013)

Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease
por: Cheng, Lesley, et al.
Publicado: (2021)

N-Glycans and Glycosylphosphatidylinositol-Anchor Act on Polarized Sorting of Mouse PrP(C) in Madin-Darby Canine Kidney Cells
por: Puig, Berta, et al.
Publicado: (2011)

In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
por: Simoneau, Steve, et al.
Publicado: (2007)

Unique Properties of the Rabbit Prion Protein Oligomer
por: Yu, Ziyao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nq1t9ad2k6pqi9nsdoki6tdm6m